Results 81 to 90 of about 757,160 (318)

Association Between Dinutuximab Beta Exposure and Post‐End‐of‐Treatment Survival in Neuroblastoma: A Weighted Patient‐Level Analysis of Three Clinical Studies

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Objectives The association between exposure to dinutuximab beta (DB) and event‐free survival (EFS) or overall survival (OS) of neuroblastoma patients was assessed using data collected during three clinical trials (five cohorts). Methods A systematic review (March 2026) was conducted to identify relevant studies (prospective; registered DB ...
Przemysław Holko, Holger N. Lode, Alberto Garaventa, Carla Manzitti, Roberto Luksch, Dominique Valteau‐Couanet, Marion Gambart, John Anderson, Juliet Gray, Adela Canete, Lucas Moreno, Aleksandra Wieczorek, Cormac Owens, Shifra Ash, Isaac Yaniv, Genevieve Laureys, Hans Loibner, Katarzyna Śladowska, Ruth Ladenstein, Paweł Kawalec   +19 more
wiley   +1 more source

Long‐Term Outcomes of Patients With Relapsed/Refractory Neuroblastoma Treated on ANBL1221: A Report From the Children's Oncology Group

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Results of COG ANBL1221 changed treatment paradigms for patients with relapsed/refractory neuroblastoma. Chemoimmunotherapy with irinotecan/temozolomide/dinutuximab is now used as both bridge therapy following suboptimal response to induction and as treatment in first relapse.
Elizabeth Sokol, Arlene Naranjo, Lulu Chen, Rajen Mody, Steven G. DuBois, Rochelle Bagatell, Navin Pinto   +6 more
wiley   +1 more source

Prognostic factors in seminomas with special respect to HCG: Results of a prospective multicenter study [PDF]

, 1999
Objective: In a prospective multicenter trial, it was our intention to elucidate clinical prognostic factors of seminomas with special reference to the importance of human chorionic gonadotropin (HCG) elevations in histologically pure seminomas. Methods:
Dieckmann, K. P., Mann, K., Weissbach, L., Löhrs, U., Bussar-Maatz, R., Schubert, G. E., Fassbinder, J., Hartmann, M.   +7 more
core   +1 more source

Commentary: The Circulatory Effects of Increased Hydrostatic Pressure Due to Immersion and Submersion

Frontiers in Physiology, 2022
Jacques Regnard, Malika Bouhaddi, Olivier Castagna, Olivier Castagna, Laurent Mourot, Laurent Mourot   +5 more
doaj   +1 more source

PROGNOSTIC FACTORS IN CROHN’S DISEASE

Alʹmanah Kliničeskoj Mediciny, 2016
The paper contains a review of the literature data concerning the demographic, clinical, laboratory, genetic, immunohistochemical, endoscopic, and imaging features with a potential role of prognostic factors for clinical management of patients with Crohn’
O. B. Shchukina
doaj   +1 more source

Consensus of potential modifiable prognostic factors for persistent pain after a first episode of nonspecific idiopathic, non-traumatic neck pain: results of nominal group and Delphi technique approach

BMC Musculoskeletal Disorders, 2020
Background Identify and establish consensus regarding potential prognostic factors for the development of chronic pain after a first episode of idiopathic, non-traumatic neck pain.
Martine Verwoerd, Harriet Wittink, Francois Maissan, Rob Smeets   +3 more
doaj   +1 more source

Measurable Residual Disease Monitoring During Treatment for Pediatric Acute Myeloid Leukemia in First Relapse

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Survival after relapse in pediatric acute myeloid leukemia (AML) remains poor, highlighting the critical importance of identifying prognostic factors to guide optimal relapse management. Methods We investigated the prognostic impact of multiparameter flow cytometry (MFC) measurable residual disease (MRD) in 188 patients with first ...
Camilla Poulsen, Kristian Juul Sandahl, Lene Karlsson, Jonas Abrahamsson, Nira Arad‐Cohen, Daniel Cheuk, Barbara De Moerloose, Linda Fogelstrand, Jose Maria Fernandez Navarro, Bianca F. Goemans, Kirsi Jahnukainen, Gertjan Kaspers, Zhanna Kovalova, Monica Cheng Munthe‐Kaas, Ulrika Norén‐Nyström, Josefine Palle, Ramune Pasauliene, Cornelis Jan Pronk, Kadri Saks, Anne Tierens, Henrik Hasle, Kristian Løvvik Juul‐Dam   +21 more
wiley   +1 more source

Prognostic factors of tumor recurrence in completely resected non-small cell lung cancer [PDF]

, 2013
Apichat Tantraworasin,1 Somcharean Seateang,1 Nirush Lertprasertsuke,2 Nuttapon Arreyakajohn,3 Choosak Kasemsarn,4 Jayanton Patumanond5 1General Thoracic Unit, Department of Surgery, Faculty of Medicine, Chiang Mai University Hospital, Chiang Mai ...
Tantraworasin A, Seateang S, Arreyakajohn N, Lertprasertsuke N, Kasemsarn C, Patumanond J   +5 more
core  

Use of classical and novel biomarkers as prognostic risk factors for localised prostate cancer : a systematic review [PDF]

, 2009
Objectives: To provide an evidence-based perspective on the prognostic value of novel markers in localised prostate cancer and to identify the best prognostic model including the three classical markers and investigate whether models incorporating ...
P Sutcliffe, Clarke, N., Younger, P, Roome, C, Clarke, Noel W., A Wilkinson, Sutcliffe, P., Rogers, G, A Rees, Hummel, S., Sutcliffe, P. (Paul), Staffurth, John Nicholas, J Staffurth, Somerville, M, F Hamdy, Young, T., Hamdy, F., E Simpson, Wilkinson, A., Rees, A. (Angie), Hamdy, Freddie C., Zawada, A, S Hummel, Taylor, Rod S., T Young, Simpson, E. L. (Emma L.), Staffurth, J., Elston, J, N Clarke, Simpson, E., Garside, R, Wilkinson, A. (Anna), Rees, A., Young, T. (Tracey)   +33 more
core   +1 more source

T2* Magnetic Resonance Imaging Uncovers Hemosiderin Burden in Pediatric Hemophilia: A Call for Sensitive Imaging Biomarkers

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Hemophilic arthropathy remains the leading morbidity in hemophilia despite modern prophylaxis, and early joint damage may be missed by routine exams. This study explored T2* MRI as a noninvasive biomarker of hemosiderin deposition in pediatric hemophilia.
Jessica Garcia, Tarique Hussain, Jeanne Dillenbeck, Matthew Hammer, Annette von Drygalski, Guy Young, Ayesha Zia   +6 more
wiley   +1 more source